(Q44722105)

5 December 2017

title

Adenosine Deaminase Activity in Patients with Carcinoma of the Bladder (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

30 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

30 August 2023

author name string

G. Sufrin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A642089

30 August 2023

G. L. Tritsch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A642089

30 August 2023

A. Mittelman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A642089

30 August 2023

G. P. Murphy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A642089

30 August 2023

language of work or name

English

0 references

publication date

1 March 1978

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0022534717574868?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

https://api.elsevier.com/content/article/PII:S0022534717574868?httpAccept=text/plain

30 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2957486-8

30 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

30 August 2023

1 reference

5 December 2017

volume

119

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

343-346

1 reference

Immunologic unreactivity in bladder cancer patients

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Abnormalities of cell-mediated immunocompetence in genitourinary cancer

30 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.

30 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Antigenic Deletion and Prognosis of Patients with Stage a Transitional Cell Bladder Carcinoma

30 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

30 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

30 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment

30 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Changes in cell-mediated cytotoxicity during the clinical course of patients with bladder carcinoma

30 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases

30 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms

30 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Tumors of the urinary bladder

30 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Meaningful clinical classification of therapeutic responses to anticancer drugs

30 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Automated determination of adenosine aminohydrolase in human plasma and erythrocytes by continuous flow analysis

30 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Adenosine deaminase levels in blood type A patients with metastatic tumor

30 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Immunobiology of human bladder cancer.

30 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Lymphocyte stimulation in urologic cancer patients.

30 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease

30 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Correction of Severe Combined Immunodeficiency by Fetal Liver Cells

30 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency

30 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Immune response to urinary bladder tumours in man

30 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

The Interaction of Host Immunocompetence and Tumor Aggressiveness in Superficial Bladder Carcinoma

30 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

T Lymphocytes in Bladder and Prostatic Cancer Patients

30 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

Evidence for Control of Several Different Tissue-specific Isozymes of Adenosine Deaminase by a le Genetic Locus

30 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)57486-8

30 August 2023

Identifiers

1 reference

5 December 2017

1 reference